vs

Side-by-side financial comparison of Canaan Inc. (CAN) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $20.8M, roughly 1.6× Canaan Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -28.1%, a 9.6% gap on every dollar of revenue.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CAN vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.6× larger
RXST
$32.6M
$20.8M
CAN
Higher net margin
CAN
CAN
9.6% more per $
CAN
-18.4%
-28.1%
RXST

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CAN
CAN
RXST
RXST
Revenue
$20.8M
$32.6M
Net Profit
$-3.8M
$-9.2M
Gross Margin
99.9%
77.5%
Operating Margin
-15.9%
-34.8%
Net Margin
-18.4%
-28.1%
Revenue YoY
-18.9%
Net Profit YoY
-54.1%
EPS (diluted)
$-0.05
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
RXST
RXST
Q4 25
$20.8M
$32.6M
Q3 25
$13.8M
$30.3M
Q2 25
$11.4M
$33.6M
Q1 25
$37.9M
Q4 24
$40.2M
Q3 24
$10.2M
$35.3M
Q2 24
$4.8M
$34.9M
Q1 24
$29.5M
Net Profit
CAN
CAN
RXST
RXST
Q4 25
$-3.8M
$-9.2M
Q3 25
$-1.5M
$-9.8M
Q2 25
$-11.9M
$-11.8M
Q1 25
$-8.2M
Q4 24
$-5.9M
Q3 24
$-10.4M
$-6.3M
Q2 24
$-5.4M
$-6.1M
Q1 24
$-9.1M
Gross Margin
CAN
CAN
RXST
RXST
Q4 25
99.9%
77.5%
Q3 25
99.9%
79.9%
Q2 25
99.9%
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
99.9%
71.4%
Q2 24
99.8%
69.5%
Q1 24
70.1%
Operating Margin
CAN
CAN
RXST
RXST
Q4 25
-15.9%
-34.8%
Q3 25
-27.0%
-40.1%
Q2 25
-45.5%
-41.6%
Q1 25
-28.2%
Q4 24
-21.5%
Q3 24
-77.2%
-26.1%
Q2 24
-193.9%
-23.9%
Q1 24
-36.2%
Net Margin
CAN
CAN
RXST
RXST
Q4 25
-18.4%
-28.1%
Q3 25
-11.0%
-32.4%
Q2 25
-104.4%
-35.0%
Q1 25
-21.6%
Q4 24
-14.8%
Q3 24
-102.7%
-17.9%
Q2 24
-112.3%
-17.4%
Q1 24
-30.8%
EPS (diluted)
CAN
CAN
RXST
RXST
Q4 25
$-0.05
$-0.22
Q3 25
$-0.02
$-0.24
Q2 25
$-0.25
$-0.29
Q1 25
$-0.20
Q4 24
$-0.14
Q3 24
$-0.16
Q2 24
$-0.16
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
$6.2M
Stockholders' EquityBook value
$52.4M
$275.7M
Total Assets
$92.5M
$311.8M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Total Debt
CAN
CAN
RXST
RXST
Q4 25
$6.2M
Q3 25
$6.2M
Q2 25
$6.2M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CAN
CAN
RXST
RXST
Q4 25
$52.4M
$275.7M
Q3 25
$44.7M
$276.0M
Q2 25
$33.8M
$278.0M
Q1 25
$279.3M
Q4 24
$281.2M
Q3 24
$43.6M
$277.3M
Q2 24
$56.8M
$275.2M
Q1 24
$163.9M
Total Assets
CAN
CAN
RXST
RXST
Q4 25
$92.5M
$311.8M
Q3 25
$81.7M
$308.5M
Q2 25
$78.0M
$309.0M
Q1 25
$313.0M
Q4 24
$318.6M
Q3 24
$69.3M
$310.5M
Q2 24
$73.7M
$305.5M
Q1 24
$183.2M
Debt / Equity
CAN
CAN
RXST
RXST
Q4 25
0.12×
Q3 25
0.14×
Q2 25
0.18×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAN
CAN
RXST
RXST
Operating Cash FlowLast quarter
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAN
CAN
RXST
RXST
Q4 25
$-1.1M
Q3 25
$-1.2M
Q2 25
$-4.4M
Q1 25
$-8.8M
Q4 24
$-4.3M
Q3 24
$650.0K
Q2 24
$-4.0M
Q1 24
$-9.3M
Free Cash Flow
CAN
CAN
RXST
RXST
Q4 25
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
CAN
CAN
RXST
RXST
Q4 25
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
CAN
CAN
RXST
RXST
Q4 25
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAN
CAN

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons